Bikanta

Bikanta is a startup biotech company engaged in the development of clinical products that focus on detection of cancer by inserting fluorescent nanodiamonds.[1][2] In 2014, Bikanta participated in the Y Combinator program and was one of the four companies backed by Y Combinator.[3][4][5] The company claims to have developed a cancer screening technology capable of detecting cancer early by use of nanodiamonds capable of stopping cancer from spreading any further.[6][7][8] In an interview with Techcrunch, founder Dr. Ambika Bumb said that current technologies cannot detect micrometastatic tumors, whereas Bikanta's can.[9]

The company was founded in 2013 and is based at Berkeley, California.[10] Bikanta has raised $120k in seed funding from 5 Investors in 2014.[11][12]

Bikanta
Startup company
Industry Biotechnology, Clinical Diagnostics
Founded Berkeley, California, United States (October 2013 (2013-10))
Founder Ambika Bumb
Headquarters Berkeley, California, United State
Products Silica Coated Fluorescent Nanodiamonds
Website bikanta.com

Awards and Recognitions

Best Diagnostic Startup of the Year: Named one of four Best Diagnostic startups by QB3.[13]

Orloff Award: The Orloff Award was granted to Bikanta by National Heart Lung Blood Institute for Technical Achievement

Silicon Valley Boomer Venture Competition: On June 25th, 2014, Bikanta won 1st place at the 11th Annual Business Plan Competition of The Silicon Valley Boomer Venture Summit. [14]

Y Combinator: In Spring 2014, Bikanta was named as one of the earliest biotech Y Combinator - backed companies.

CLSI FAST Company: In Fall 2014, Bikanta participated in the California Life Sciences Institute's FAST Advisory Program.[15]

Capital Connections Business Competition: On February 25, 2016, Bikanta won 1st place in the annual Capital Connections pitch competition hosted by the nonprofit Alliance for Community Development.

References

  1. ↑ Ron Leuty (21 October 2015). "Most innovative biotechs? QB3 makes its picks for 10th anniversary". BizJournals. Retrieved 16 July 2016.
  2. ↑ "Early-stage biotech investment takes off as life science startups make Demo Day debut". Techiatric. Retrieved 16 July 2016.
  3. ↑ KIA KOKALITCHEVA (19 August 2014). "4 Y Combinator standout startups so far". VentureBeat. Retrieved 16 July 2016.
  4. ↑ Chris Wiltz (27 August 2014). "Y-Combinator is Betting on These 7 Medtech Startups in 2014 - Bikanta". Mddionline. Retrieved 16 July 2016.
  5. ↑ Nancy Owano (11 August 2014). "Nanodiamond tech lights new path in medical diagnostics". Phys.org. Retrieved 16 July 2016.
  6. ↑ Leonard Brillson. "Issue 19—Spring 2016". Materials Research Society. Retrieved 16 July 2016.
  7. ↑ "Bikanta's (YC S14) Tiny Diamonds Find Cancer Before It Spreads". Y Combinator. Retrieved 16 July 2016.
  8. ↑ Charles Costa (30 June 2016). "Bikanta's Tiny Diamonds Find Cancer Before It Spreads". SnapMunk. Retrieved 16 July 2016.
  9. ↑ Sarah Buhr (7 August 2014). "Bikanta's Tiny Diamonds Find Cancer Before It Spreads". TechCrunch. Retrieved 16 July 2016.
  10. ↑ Amar D. Gupta (24 July 2015). "From Nanodiamonds to Car Service, South Asian Businesses Find Senior Market". NewAmerica Media. Retrieved 16 July 2016.
  11. ↑ Sarah Buhr (19 August 2014). "YC Demo Day Session 1: Gingko Bioworks, Bikanta, Checkr, WalkSource, ClearTax, And More". TechCrunch. Retrieved 16 July 2016.
  12. ↑ "Bikanta Obtains $120,000 Seed Financing". Xconomy. Retrieved 16 July 2016.
  13. ↑ "Diagnostics Startup of the Year". Retrieved 2016-07-25.
  14. ↑ "Silicon Valley Boomer Venture Summit Names Bikanta Competition Winner". Retrieved 2016-07-25.
  15. ↑ "Bikanta - California Life Sciences Association". 2015-07-31. Retrieved 2016-07-25.
This article is issued from Wikipedia - version of the 11/13/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.